66 Results for "

uPA

" in MedChemExpress (MCE) Product Catalog:
Products (66)

66 Results for "uPA" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-111056
CAS No.: 940290-58-4
Purity:  99.72%
Target:  

Ser/Thr Protease

Research Areas:  

Cancer

UK122 is a potent and selective urokinase-type plasminogen activator (uPA) inhibitor with an IC50 of 0.2 μM. UK122 shows no or little inhibition of tissue-type PA (tPA), plasmin, thrombin, and trypsin (all IC50>100 μM). UK122, 4-oxazolidinone analogue, is an anticancer agent and inhibits cancer cell migration and invasion .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-111192
CAS No.: 892243-35-5
Purity:  ≥98.0%
Target:  

Ser/Thr Protease

Research Areas:  

Cancer

IPR-803 is a potent inhibitor of the uPAR·uPA protein-protein interaction (PPI). IPR-803 binds directly to uPAR with sub-micromolar affinity. IPR-803 displays anti-tumor activity .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-111056A
Target:  

Ser/Thr Protease

Research Areas:  

Cancer

UK122 hydrochloride is a potent and selective urokinase-type plasminogen activator (uPA) inhibitor with an IC50 of 0.2 μM. UK122 hydrochloride shows no or little inhibition of tissue-type PA (tPA), plasmin, thrombin, and trypsin (all IC50s > 100 μM). UK122 hydrochloride, a 4-oxazolidinone analogue, is an anticancer agent and inhibits cancer cell migration and invasion .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-16511
CAS No.: 590368-25-5
Synonyms: WX-671
Target:  

PAI-1 Ser/Thr Protease

Research Areas:  

Infection Cancer

Upamostat (WX-671), a prodrug of WX-UK1, is an orally active serine protease inhibitor. Upamostat inhibits the urokinase-type plasminogen activator (uPA) system, blocking the plasminogen activation process mediated by it, thereby suppressing the invasion, migration and metastasis of tumor cells. Upamostat can be used in the research of metastatic breast cancer and locally advanced pancreatic cancer .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P2230
CAS No.: 220334-14-5
Synonyms: A6 Peptide
Target:  

PAI-1

Research Areas:  

Cancer

Angstrom6 (A6 Peptide) is an 8 amino-acid peptide derived from single-chain urokinase plasminogen activator (scuPA) and interferes with the uPA/uPAR cascade and abrogates downstream effects. Angstrom6 binds to CD44 resulting in the inhibition of migration, invasion, and metastasis of tumor cells, and the modulation of CD44-mediated cell signaling .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W018723
CAS No.: 2498-50-2
Synonyms: p-Aminobenzamidine dihydrochloride
Target:  

Ser/Thr Protease PAI-1

Research Areas:  

Cardiovascular Disease Cancer

4-Aminobenzamidine (p-Aminobenzamidine) dihydrochloride is a strong trypsin inhibitor. 4-Aminobenzamidine dihydrochloride acts as an orally active urokinase type plasminogen activator (uPA) inhibitor (Ki=82 μM). 4-Aminobenzamidine dihydrochloride can be used for cardiovascular diseases and anti-tumor study .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-126361
CAS No.: 2254001-81-3
Target:  

Ser/Thr Protease PAI-1

Research Areas:  

Inflammation/Immunology

ZK824190 is an orally available and selective urokinase plasminogen activator (uPA) inhibitor as a potential treatment for multiple sclerosis. IC50s of 237, 1600 and 1850 nM for uPA, tPA, and Plasmin, respectively .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-126361A
CAS No.: 2629177-12-2
Purity:  99.61%
Target:  

Ser/Thr Protease PAI-1

Research Areas:  

Inflammation/Immunology

ZK824190 hydrochloride is an orally available and selective urokinase plasminogen activator (uPA) inhibitor as a potential treatment for multiple sclerosis. IC50s of 237, 1600 and 1850 nM for uPA, tPA, and Plasmin, respectively .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P78017
Purity:  ≥ 95%, as determined by reducing SDS-PAGE or Bis-Tris PAGE.
Synonyms: PLAU; Urokinase; ATF; uPA; URK; u-PA; BDPLT5; QPD
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P71050
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Urokinase-Type Plasminogen Activator; U-Plasminogen Activator; uPA; PLAU
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P991200

Target:  

HCV Claudin

Research Areas:  

Infection

OM-7D3-B3 is an antibody-based antiviral agent targeting the tight junction protein CLDN1 (Kd=4 nM). By binding to the first extracellular domain of CLDN1, OM-7D3-B3 disrupts the formation of the CLDN1-CD81 co-receptor complex, thereby effectively inhibiting the entry of hepatitis C virus (HCV). OM-7D3-B3 not only prevents de novo and chronic HCV infections in humanized liver chimeric mice and uPA-SCID mice transplanted with human livers, but also exhibits favorable safety with no toxic effects observed. OM-7D3-B3 serves as a critical tool for research on HCV infection mechanisms and antiviral drug development .
loading...
    loading...
Cat. No.: HY-100415
CAS No.: 220355-63-5
Purity:  96.13%
Synonyms: WX-UK1; UKI-1C
Target:  

PAI-1 Ser/Thr Protease

Research Areas:  

Cancer

UKI-1 (WX-UK1) is a potent urokinase-type plasminogen activator (uPA) inhibitor with a Ki of 0.41 μM. UKI-1 is also a low molecular weight serine protease inhibitor. UKI-1 is a potent antimetastatic agent and inhibits the invasive capacity of carcinoma cells .
loading...
    loading...
Cat. No.: HY-101214
CAS No.: 256477-09-5
Purity:  ≥98.0%
Target:  

PAI-1

Research Areas:  

Inflammation/Immunology

UK-371804 is a urokinase-type plasminogen activator (uPA) inhibitor with a Ki of 10 nM.
loading...
    loading...
Cat. No.: HY-P990552A

Target:  

PAI-1 Integrin

Research Areas:  

Cancer

huATN-658 is an inhibitor that specifically targets the DIII domain of human urokinase plasminogen activator receptor (uPAR). huATN-658 neutralizes uPAR function by blocking the interaction between uPAR and integrins, without interfering with the binding of uPA or vitronectin to uPAR. huATN-658 inhibits the proliferation and invasion of breast cancer cells, slows the growth of primary breast tumors, reduces breast cancer-induced bone lesions and decreases osteoclast activity. huATN-658 also alters the gene expression of the TGF-β receptor complex signaling pathway. huATN-658 exerts synergistic anticancer effects when combined with Zoledronic Acid (HY-13777), and does not cause physiological or behavioral abnormalities in immunodeficient mice. huATN-658 can be used in research related to breast cancer, metastatic breast cancer and breast cancer-induced bone disease .
loading...
    loading...
Cat. No.: HY-P11446
CAS No.: 254729-66-3
Research Areas:  

Cancer

AE105 is a 9-mer peptide probe targeting the urokinase-type plasminogen activator receptor (uPAR). AE105 binds tightly to the uPA-binding cavity of uPAR. AE105 can be used for the study of cancer .
loading...
    loading...
Cat. No.: HY-P4338
CAS No.: 65147-16-2
Target:  

PAI-1

Research Areas:  

Others

Glutaryl-Gly-Arg-AMC is a peptide substrate of urokinase plasminogen activator (uPA) .
loading...
    loading...
Cat. No.: HY-108447
CAS No.: 443776-49-6
Purity:  ≥99.0%
Research Areas:  

Infection Cancer

BC-11 hydrobromide is a selective TMPRSS2 inhibitor (TMPRSS2 is a key host cellular factor for viral entry and SARS-CoV-2 pathogenesis), and a selective urokinase (uPA) inhibitor (IC50=8.2 μM). BC-11 hydrobromide is cytotoxic to triple-negative MDA-MB231 breast cancer cells. BC-11 hydrobromide is used in research on viral infections and cancer .
loading...
    loading...
Cat. No.: HY-120516
CAS No.: 1228357-04-7
Purity:  99.97%
Target:  

PAI-1

Research Areas:  

Cardiovascular Disease

CDE-096 is a potent inhibitor of PAI-1. CDE-096 prevents PAI-1 from inactivating tPA and uPA with similar potency (IC50=30 and 25 nM, respectively) and is active against glycosylated PAI-1, as well as PAI-1 derived from several species (IC50=19, 22 and 18 nM for murine, rat, and Porcine PAI-1, respectively) .
loading...
    loading...
Cat. No.: HY-114330A
CAS No.: 2436760-76-6
Purity:  99.03%
Target:  

PAI-1 Ser/Thr Protease

Research Areas:  

Inflammation/Immunology

ZK824859 hydrochloride is an oral available and selective urokinase plasminogen activator (uPA) inhibitor with IC50s of 79 nM, 1580 nM and 1330 nM for human uPA, tPA, and plasmin, respectively .
loading...
    loading...
Cat. No.: HY-132187
CAS No.: 1670-26-4
Purity:  99.50%
Sphingosylphosphorylcholine is a bioactive lipid and a major component of plasma high-density lipoprotein that binds to OGR1 with a Kd of 33.3 nM. Sphingosylphosphorylcholine triggers delayed phosphorylation of Smad2, upregulates α-SMA expression, and activates TRPM3. Sphingosylphosphorylcholine reduces Apoptosis and upregulates the expression of uPA and its receptor uPA-R. Sphingosylphosphorylcholine exerts anti-apoptotic, anti-cardiac hypertrophy and pro-wound healing effects. Sphingosylphosphorylcholine induces scratching behavior in mice. Sphingosylphosphorylcholine is used in studies related to atopic dermatitis, promyelocytic leukemia, heart failure, myocardial ischemia/reperfusion injury, ovarian cancer, breast cancer, pancreatic cancer, and skin wound healing disorders in genetically impaired healing diabetes .
loading...
    loading...